Additional file 12 of A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma

Authors :: Li, Ning
Wu, Tao
Hong, Yong-Gui
Guo, Yan-Zhen
Cheng, Yu-Feng
Ma, Yi-Jie
Bie, Liang-Yu
Cui, Dong-Hai
Gao, Xiao-Hui
Tan, Bing-Xu
Li, Bao-Sheng
Luo, Su-Xia
Wang, Jun-Sheng
Publication Year :: 2023
Publisher :: figshare, 2023.
Abstract: Additional file 12: Table S10. Multivariate analysis of the correlation between biomarkers and overall survival (OS)

Full Text Access

Tools